Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1990-1-5
|
pubmed:abstractText |
Urinary excretion of 6-keto-PGF1 alpha and 2,3 dinor-6-keto-PGF1 alpha, as indices of the renal and systemic production of prostaglandins, was measured during water immersion in a group of 6 healthy volunteers both in the presence and absence of dopamine blockade by the dopamine receptor antagonist, metoclopramide. Urinary flow rate and excretion of both sodium and 6-keto-PGF1 alpha increased during water immersion, while plasma renin activity and plasma aldosterone were reduced. Urinary kallikrein and 2,3 dinor-6-keto-PGF1 alpha also tended to increase during water immersion. Administration of metoclopramide significantly reduced 6-keto-PGF1 alpha and sodium excretion during water immersion, but produced no changes in plasma renin activity or in 2,3 dinor-6-keto-PGF1 alpha. Plasma aldosterone concentrations after metoclopramide were similar to those observed in the pre-immersion period. An increased synthesis of the vasodilator and natriuretic prostacyclin in the kidney might play a role in the response to water immersion. The reduced sodium and 6-keto-PGF1 alpha excretion observed after metoclopramide administration suggests that dopamine might induce prostacyclin synthesis in the kidney during water immersion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/6-Ketoprostaglandin F1 alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Epoprostenol,
http://linkedlifedata.com/resource/pubmed/chemical/Kallikreins,
http://linkedlifedata.com/resource/pubmed/chemical/Metoclopramide,
http://linkedlifedata.com/resource/pubmed/chemical/Renin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0391-4097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
597-600
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2511238-6-Ketoprostaglandin F1 alpha,
pubmed-meshheading:2511238-Adult,
pubmed-meshheading:2511238-Aldosterone,
pubmed-meshheading:2511238-Blood Pressure,
pubmed-meshheading:2511238-Epoprostenol,
pubmed-meshheading:2511238-Heart Rate,
pubmed-meshheading:2511238-Humans,
pubmed-meshheading:2511238-Immersion,
pubmed-meshheading:2511238-Kallikreins,
pubmed-meshheading:2511238-Male,
pubmed-meshheading:2511238-Metoclopramide,
pubmed-meshheading:2511238-Radioimmunoassay,
pubmed-meshheading:2511238-Renin
|
pubmed:year |
1989
|
pubmed:articleTitle |
Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man.
|
pubmed:affiliation |
Istituto di clinica Medica, Università di Verona, Italy.
|
pubmed:publicationType |
Journal Article
|